UTRS Stock - Minerva Surgical, Inc.
Unlock GoAI Insights for UTRS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|
| Revenue | $50.29M | $52.10M | $37.77M | $26.01M |
| Gross Profit | $27.24M | $30.52M | $19.12M | $11.80M |
| Gross Margin | 54.2% | 58.6% | 50.6% | 45.4% |
| Operating Income | $-30,899,000 | $-29,145,000 | $-15,390,000 | $-19,637,000 |
| Net Income | $-34,112,000 | $-21,464,000 | $-18,263,000 | $-52,046,000 |
| Net Margin | -67.8% | -41.2% | -48.4% | -200.1% |
| EPS | $-23.68 | $-14.98 | $-17.91 | $-75.29 |
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Visit WebsiteEarnings History & Surprises
UTRSEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Feb 13, 2025 | — | — | — | — |
Q4 2024 | Dec 27, 2024 | — | — | — | — |
Q3 2024 | Aug 9, 2024 | $-0.54 | — | — | — |
Q2 2024 | Jun 14, 2024 | — | — | — | — |
Q1 2024 | Mar 19, 2024 | $-0.54 | — | — | — |
Q4 2023 | Nov 13, 2023 | $-1.00 | $-0.81 | +19.0% | ✓ BEAT |
Q3 2023 | Aug 2, 2023 | $-1.80 | $-1.00 | +44.4% | ✓ BEAT |
Q2 2023 | May 2, 2023 | $-2.20 | $-2.40 | -9.1% | ✗ MISS |
Q1 2023 | Mar 21, 2023 | $0.21 | $-4.00 | -2004.8% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-5.60 | $-8.00 | -42.9% | ✗ MISS |
Q3 2022 | Aug 9, 2022 | $-6.80 | $-4.00 | +41.2% | ✓ BEAT |
Q2 2022 | May 11, 2022 | $-6.20 | $-7.60 | -22.6% | ✗ MISS |
Q1 2022 | Mar 8, 2022 | $-0.29 | $-0.26 | +10.3% | ✓ BEAT |
Q4 2021 | Dec 2, 2021 | $-0.44 | $4.87 | +1206.8% | ✓ BEAT |
Q4 2021 | Oct 25, 2021 | — | $-13.82 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-14.66 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.31 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-7.18 | — | — |
Latest News
Frequently Asked Questions about UTRS
What is UTRS's current stock price?
What is the analyst price target for UTRS?
What sector is Minerva Surgical, Inc. in?
What is UTRS's market cap?
Does UTRS pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to UTRS for comparison